PAM
NVO

Parvin Asset Management’s Novo Nordisk NVO Stock Holding History

Parvin Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Hold
2,015
– – 0.08% 186
2026
Q1 		$74.1K Hold
2,015
– – 0.05% 196
2025
Q4 		$103K Sell
2,015
-1,200
-37% -$61.4K 0.08% 159
2025
Q3 		$178K Buy
3,215
+50
+2% +$2.93K 0.16% 125
2025
Q2 		$218K Buy
3,165
+70
+2% +$4.76K 0.22% 105
2025
Q1 		$215K Sell
3,095
-1,000
-24% -$82.6K 0.24% 106
2024
Q4 		$352K Buy
+4,095
New +$443K 0.37% 78

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Parvin Asset Management's NVO Position: Q2 2026 in Review

Parvin Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 2,015 shares worth $96.6K. The position accounts for 0.08% of the portfolio, ranked #186.

Parvin Asset Management first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $352K in Q4 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Parvin Asset Management held 2,015 shares of Novo Nordisk worth $96.6K as of Q2 2026.
  • Parvin Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.08% of Parvin Asset Management's portfolio in Q2 2026, its #186 holding.
  • Parvin Asset Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Parvin Asset Management's Novo Nordisk position peaked at $352K in Q4 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.